SAB BIOTHERAPEUTICS, INC. (SABS) Net margin 2020–2024
SAB BIOTHERAPEUTICS, INC. (SABS) net profit margin by fiscal year — reported net income divided by reported revenue.
-2579.0%FY2024 · since FY2020: 36.4% → -2579.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -2579.0% | -694.5 pp |
| FY2023 | -1884.5% | -1806.1 pp |
| FY2022 | -78.4% | -50.2 pp |
| FY2021 | -28.2% | -64.6 pp |
| FY2020 | 36.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABS financial trends
SABS RevenueSABS Net incomeSABS Gross profitSABS Gross marginSABS Operating incomeSABS Operating marginSABS Operating cash flowSABS Free cash flowSABS Capital expendituresSABS Return on equitySABS Stock buybacksSABS Dividends paidSABS Total assetsSABS Total liabilitiesSABS Shareholders’ equitySABS overview →